Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
Cécile Schiffer Mannioui(Cerenis Therapeutics (France)), Andrew M. Scharenberg(CTI BioPharma (Italy)), Agnès Gouble(Txcell (France)), Laëtitia Lemaire(Txcell (France)), Laurent Poirot(Txcell (France)), Román Galetto(Txcell (France)), Sylvain Arnould(Servier (France)), Julianne Smith(Case Western Reserve University)
Cited by 1
Related Papers
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897
TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization
|Cell|2002|751
A Unified Nomenclature for the Superfamily of TRP Cation Channels
|Molecular Cell|2002|679